Curetis Goes Dutch With Dual Euronext Listing For IPO
This article was originally published in Clinica
Executive Summary
German molecular diagnostics specialist Curetis AG is to become a newly incorporated Dutch holding, Curetis N.V., and list its shares on the Euronext stock exchanges in Amsterdam and Brussels. The announcement comes just under three months after the company told Clinica it planned to turn to the public markets for its next fundraising round.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.